Free Trial

Mereo BioPharma Group (MREO) SEC Filings & 10K Form

Mereo BioPharma Group logo
$4.28
+0.07 (+1.66%)
(As of 11/1/2024 ET)

Recent Mereo BioPharma Group SEC Filings

DateFilerForm TypeView
09/16/2024
7:46 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:47 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:48 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:49 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:50 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:47 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:49 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:49 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:50 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:57 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:05 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
5:13 PM
Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:35 PM
Mereo BioPharma Group (Subject)
PAKIANATHAN DEEPIKA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:19 AM
Mereo BioPharma Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
7:09 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
10:46 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
06/27/2024
3:15 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:13 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:13 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:14 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:15 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:21 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:53 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
Form 144/A
06/24/2024
5:58 PM
Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
Form 144/A
06/24/2024
6:00 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144/A
06/24/2024
6:04 PM
Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
Form 144/A
06/24/2024
6:04 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
Form 144/A
06/20/2024
3:27 PM
Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:30 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:32 PM
Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:34 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:16 PM
Mereo BioPharma Group (Issuer)
Rosen David Efraim (Reporting)
Rubric Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Crypto Crash Ahead? (27 Experts Weigh In) (Ad)

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.
06/11/2024
8:15 PM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2024
11:15 PM
Mereo BioPharma Group (Filer)
Form EFFECT
05/23/2024
8:54 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:38 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
3:16 PM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:49 PM
Mereo BioPharma Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/15/2024
3:19 PM
Mereo BioPharma Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
6:36 AM
Mereo BioPharma Group (Filer)
Form ARS
04/24/2024
6:30 AM
Mereo BioPharma Group (Filer)
Form DEF 14A
04/16/2024
1:58 PM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
04/15/2024
6:30 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
4:20 PM
Mereo BioPharma Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
5:51 PM
Mereo BioPharma Group (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
1:11 PM
Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G/A
02/14/2024
11:36 AM
MANGROVE PARTNERS IM, LLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
02/13/2024
4:26 PM
Mereo BioPharma Group (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/05/2024
4:09 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
01/23/2024
3:16 PM
Mereo BioPharma Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/08/2024
6:08 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
3:16 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:17 PM
Mereo BioPharma Group (Issuer)
Shames Daniel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:18 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Bender Jeremy (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Roberts Justin Hunter (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Yoskowitz Marc J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Jacquet Pierre (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
WYZGA MICHAEL S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Jenkins Annalisa (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Fox Chrisitne Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:16 PM
Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2023
3:16 PM
Mereo BioPharma Group (Filer)
Form 8-A12B/A
11/29/2023
3:15 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2023
7:45 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/16/2023
6:01 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2023
6:56 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/13/2023
6:31 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/08/2023
6:06 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/06/2023
6:30 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/02/2023
6:30 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MREO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners